Identification of SARS-CoV-2 entry inhibitors among already approved drugs

por Yang, Li, Pei, Rong-juan, Li, Heng, Ma, Xin-na, Zhou, Yu, Zhu, Feng-hua, He, Pei-lan, Tang, Wei, Zhang, Ye-cheng, Xiong, Jin, Xiao, Shu-qi, Tong, Xian-kun, Zhang, Bo, Zuo, Jian-ping
Publicado 2020

Histone deacetylase 3 promotes innate antiviral immunity through deacetylation of TBK1

por Tang, Jie-lin, Yang, Qi, Xu, Chong-hui, Zhao, He, Liu, Ya-ling, Liu, Can-yu, Zhou, Yuan, Gai, Dong-wei, Pei, Rong-juan, Wang, Yun, Hu, Xue, Zhong, Bo, Wang, Yan-yi, Chen, Xin-wen, Chen, Ji-zheng
Publicado 2020

Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase I...

por Shu, Ya-Jun, He, Jian-Feng, Pei, Rong-Juan, He, Peng, Huang, Zhu-Hang, Chen, Shao-Min, Ou, Zhi-Qiang, Deng, Jing-Long, Zeng, Pei-Yu, Zhou, Jian, Min, Yuan-Qin, Deng, Fei, Peng, Hua, Zhang, Zheng, Wang, Bo, Xu, Zhong-Hui, Guan, Wu-Xiang, Hu, Zhong-Yu, Zhang, Ji-Kai
Publicado 2021

Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III...

por Wang, Xuan-Yi, Mahmood, Syed Faisal, Jin, Fang, Cheah, Wee Kooi, Ahmad, Muhammad, Sohail, Mian Amjad, Ahmad, Waheed, Suppan, Vijaya K., Sayeed, Muneeba Ahsan, Luxmi, Shobha, Teo, Aik-Howe, Lee, Li Yuan, Qi, Yang-Yang, Pei, Rong-Juan, Deng, Wei, Xu, Zhong-Hui, Yang, Jia-Ming, Zhang, Yan, Guan, Wu-Xiang, Yu, Xiong
Publicado 2022